Qian-Xi Xu

Interpretable machine learning models for predicting tocilizumab response in rheumatoid arthritis using clinical data

Approximately 30% of patients with rheumatoid arthritis (RA) do not respond to tocilizumab (TCZ). This study aimed to predict TCZ response using machine learning models trained on clinical data. Baseline and follow-up data from patients with RA treated with TCZ were collected. Seven different machine learning models (l...